Jifu Medical

Jifu Medical has spent over a decade developing magnetically controlled capsule endoscopy technology that enables comfortable, non-invasive stomach examinations without traditional intubation procedures. The Shenzhen-based company holds both NMPA Class III medical device registration and CE certification for its Dasheng capsule endoscopy system.

Company Overview

Founded in 2011, Jifu Medical focuses exclusively on digestive tract medical devices, with headquarters in Shenzhen’s Nanshan High-tech Industrial Park and a manufacturing facility in Shenzhen Guangming District. The company has accumulated over 100 national patents through years of independent research and development.

Founder Wu Liangxin established the company with a vision to address China’s significant gastric cancer screening challenge. Traditional gastroscopy procedures suffer from low patient compliance due to discomfort and the need for sedation, while China faces a shortage of qualified endoscopy physicians. Jifu’s magnetic capsule technology offers a solution to both problems.

The company maintains GMP compliance and ISO13485 quality management certification for its production facilities. Its R&D platform has undertaken multiple national and municipal technology innovation projects.

Core Products

Dasheng Magnetically Controlled Capsule Endoscopy System

The flagship Dasheng system received NMPA Class III registration and CE certification in December 2019 after ten years of development. Unlike competing systems that use robotic arms for magnetic guidance, Jifu employs a standing-type magnetic control platform without mechanical arms, containing integrated wireless receivers.

Key specifications include:

• 136° field of view with three-lens optical system
• 4 frames per second image capture rate
• 0-50mm depth of field
• Neutral water density design for easier passage
• Extended battery life with retention monitoring

The system comprises three components: a swallowable capsule endoscope with high-definition camera, a magnetic guidance robot, and an imaging computer workstation.

Dasheng Intelligent Reading Workstation

Complementing the capsule system, Jifu developed an AI-powered reading workstation that processes gastric images, automatically filters duplicate frames, and generates examination reports. The platform reduces physician workload by completing diagnostic workflows in approximately 15 minutes.

Technology & Innovation

Jifu’s standing-type magnetic control technology differentiates it from competitors using robotic arm systems. The approach simplifies the equipment footprint while maintaining precise capsule positioning within the stomach.

The capsule design incorporates equal water density construction, allowing it to float and maneuver naturally within gastric fluids. Physicians can achieve 360-degree visualization by controlling capsule orientation through the external magnetic field.

Deep learning algorithms integrated into the reading workstation assist in lesion detection and image analysis, supporting early gastric cancer screening programs.

Market Presence

The Dasheng system has been deployed at major Chinese hospitals including Shanghai Jiao Tong University School of Medicine affiliated Ruijin Hospital. Jifu targets the gastric cancer screening market, where early detection significantly improves patient outcomes.

China’s endoscopy market exceeded 19.9 billion RMB in 2017, with domestic manufacturers holding less than 5% market share against Japanese and German competitors. Capsule endoscopy represents an opportunity for Chinese companies to establish leadership in this emerging technology segment.

Key Milestones

• 2011: Company founded in Shenzhen
• 2015: Completed angel round funding
• 2017: Series A funding led by Dingxin Capital
• 2019 (January): Additional A round financing
• 2019 (December): Dasheng system receives NMPA Class III registration and CE certification
• 2020 (September): Completed Series C funding of several hundred million RMB led by Jinglin Investment, with participation from Bojiang Capital, Toukong Donghai Investment, Yifeng Capital, and Beidouxing Investment

Frequently Asked Questions

What makes Jifu Medical’s capsule endoscopy different from competitors?

Jifu uses a standing-type magnetic control system without robotic arms, distinguishing it from competitors like Ankon Technologies that employ robotic arm guidance. The simplified platform reduces equipment complexity while maintaining diagnostic accuracy.

Does Jifu Medical have FDA clearance for the US market?

As of current information, the Dasheng system holds NMPA (China) and CE (Europe) certifications but has not received FDA clearance for the United States market.

What conditions can the Dasheng capsule endoscopy system examine?

The system is designed for gastric examination, detecting conditions including gastric ulcers, gastritis, polyps, and early-stage gastric cancer. It complements traditional endoscopy by offering a comfortable, non-invasive screening option.